Cargando…
Conducting evaluations of evidence that are transparent, timely and can lead to health-protective actions
BACKGROUND: In February 2021, over one hundred scientists and policy experts participated in a web-based Workshop to discuss the ways that divergent evaluations of evidence and scientific uncertainties are used to delay timely protection of human health and the environment from exposures to hazardou...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720912/ https://www.ncbi.nlm.nih.gov/pubmed/36471342 http://dx.doi.org/10.1186/s12940-022-00926-z |
_version_ | 1784843648599326720 |
---|---|
author | Chartres, Nicholas Sass, Jennifer B. Gee, David Bălan, Simona A. Birnbaum, Linda Cogliano, Vincent James Cooper, Courtney Fedinick, Kristi Pullen Harrison, Roy M. Kolossa-Gehring, Marike Mandrioli, Daniele Mitchell, Mark A. Norris, Susan L. Portier, Christopher J. Straif, Kurt Vermeire, Theo |
author_facet | Chartres, Nicholas Sass, Jennifer B. Gee, David Bălan, Simona A. Birnbaum, Linda Cogliano, Vincent James Cooper, Courtney Fedinick, Kristi Pullen Harrison, Roy M. Kolossa-Gehring, Marike Mandrioli, Daniele Mitchell, Mark A. Norris, Susan L. Portier, Christopher J. Straif, Kurt Vermeire, Theo |
author_sort | Chartres, Nicholas |
collection | PubMed |
description | BACKGROUND: In February 2021, over one hundred scientists and policy experts participated in a web-based Workshop to discuss the ways that divergent evaluations of evidence and scientific uncertainties are used to delay timely protection of human health and the environment from exposures to hazardous agents. The Workshop arose from a previous workshop organized by the European Environment Agency (EEA) in 2008 and which also drew on case studies from the EEA reports on ‘Late Lessons from Early Warnings’ (2001, 2013). These reports documented dozens of hazardous agents including many chemicals, for which risk reduction measures were delayed for decades after scientists and others had issued early and later warnings about the harm likely to be caused by those agents. RESULTS: Workshop participants used recent case studies including Perfluorooctanoic acid (PFOA), Extremely Low Frequency – Electrical Magnetic Fields (ELF-EMF fields), glyphosate, and Bisphenol A (BPA) to explore myriad reasons for divergent outcomes of evaluations, which has led to delayed and inadequate protection of the public’s health. Strategies to overcome these barriers must, therefore, at a minimum include approaches that 1) Make better use of existing data and information, 2) Ensure timeliness, 3) Increase transparency, consistency and minimize bias in evidence evaluations, and 4) Minimize the influence of financial conflicts of interest. CONCLUSION: The recommendations should enhance the production of “actionable evidence,” that is, reliable evaluations of the scientific evidence to support timely actions to protect health and environments from exposures to hazardous agents. The recommendations are applicable to policy and regulatory settings at the local, state, federal and international levels. |
format | Online Article Text |
id | pubmed-9720912 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-97209122022-12-06 Conducting evaluations of evidence that are transparent, timely and can lead to health-protective actions Chartres, Nicholas Sass, Jennifer B. Gee, David Bălan, Simona A. Birnbaum, Linda Cogliano, Vincent James Cooper, Courtney Fedinick, Kristi Pullen Harrison, Roy M. Kolossa-Gehring, Marike Mandrioli, Daniele Mitchell, Mark A. Norris, Susan L. Portier, Christopher J. Straif, Kurt Vermeire, Theo Environ Health Review BACKGROUND: In February 2021, over one hundred scientists and policy experts participated in a web-based Workshop to discuss the ways that divergent evaluations of evidence and scientific uncertainties are used to delay timely protection of human health and the environment from exposures to hazardous agents. The Workshop arose from a previous workshop organized by the European Environment Agency (EEA) in 2008 and which also drew on case studies from the EEA reports on ‘Late Lessons from Early Warnings’ (2001, 2013). These reports documented dozens of hazardous agents including many chemicals, for which risk reduction measures were delayed for decades after scientists and others had issued early and later warnings about the harm likely to be caused by those agents. RESULTS: Workshop participants used recent case studies including Perfluorooctanoic acid (PFOA), Extremely Low Frequency – Electrical Magnetic Fields (ELF-EMF fields), glyphosate, and Bisphenol A (BPA) to explore myriad reasons for divergent outcomes of evaluations, which has led to delayed and inadequate protection of the public’s health. Strategies to overcome these barriers must, therefore, at a minimum include approaches that 1) Make better use of existing data and information, 2) Ensure timeliness, 3) Increase transparency, consistency and minimize bias in evidence evaluations, and 4) Minimize the influence of financial conflicts of interest. CONCLUSION: The recommendations should enhance the production of “actionable evidence,” that is, reliable evaluations of the scientific evidence to support timely actions to protect health and environments from exposures to hazardous agents. The recommendations are applicable to policy and regulatory settings at the local, state, federal and international levels. BioMed Central 2022-12-05 /pmc/articles/PMC9720912/ /pubmed/36471342 http://dx.doi.org/10.1186/s12940-022-00926-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Chartres, Nicholas Sass, Jennifer B. Gee, David Bălan, Simona A. Birnbaum, Linda Cogliano, Vincent James Cooper, Courtney Fedinick, Kristi Pullen Harrison, Roy M. Kolossa-Gehring, Marike Mandrioli, Daniele Mitchell, Mark A. Norris, Susan L. Portier, Christopher J. Straif, Kurt Vermeire, Theo Conducting evaluations of evidence that are transparent, timely and can lead to health-protective actions |
title | Conducting evaluations of evidence that are transparent, timely and can lead to health-protective actions |
title_full | Conducting evaluations of evidence that are transparent, timely and can lead to health-protective actions |
title_fullStr | Conducting evaluations of evidence that are transparent, timely and can lead to health-protective actions |
title_full_unstemmed | Conducting evaluations of evidence that are transparent, timely and can lead to health-protective actions |
title_short | Conducting evaluations of evidence that are transparent, timely and can lead to health-protective actions |
title_sort | conducting evaluations of evidence that are transparent, timely and can lead to health-protective actions |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720912/ https://www.ncbi.nlm.nih.gov/pubmed/36471342 http://dx.doi.org/10.1186/s12940-022-00926-z |
work_keys_str_mv | AT chartresnicholas conductingevaluationsofevidencethataretransparenttimelyandcanleadtohealthprotectiveactions AT sassjenniferb conductingevaluationsofevidencethataretransparenttimelyandcanleadtohealthprotectiveactions AT geedavid conductingevaluationsofevidencethataretransparenttimelyandcanleadtohealthprotectiveactions AT balansimonaa conductingevaluationsofevidencethataretransparenttimelyandcanleadtohealthprotectiveactions AT birnbaumlinda conductingevaluationsofevidencethataretransparenttimelyandcanleadtohealthprotectiveactions AT coglianovincentjames conductingevaluationsofevidencethataretransparenttimelyandcanleadtohealthprotectiveactions AT coopercourtney conductingevaluationsofevidencethataretransparenttimelyandcanleadtohealthprotectiveactions AT fedinickkristipullen conductingevaluationsofevidencethataretransparenttimelyandcanleadtohealthprotectiveactions AT harrisonroym conductingevaluationsofevidencethataretransparenttimelyandcanleadtohealthprotectiveactions AT kolossagehringmarike conductingevaluationsofevidencethataretransparenttimelyandcanleadtohealthprotectiveactions AT mandriolidaniele conductingevaluationsofevidencethataretransparenttimelyandcanleadtohealthprotectiveactions AT mitchellmarka conductingevaluationsofevidencethataretransparenttimelyandcanleadtohealthprotectiveactions AT norrissusanl conductingevaluationsofevidencethataretransparenttimelyandcanleadtohealthprotectiveactions AT portierchristopherj conductingevaluationsofevidencethataretransparenttimelyandcanleadtohealthprotectiveactions AT straifkurt conductingevaluationsofevidencethataretransparenttimelyandcanleadtohealthprotectiveactions AT vermeiretheo conductingevaluationsofevidencethataretransparenttimelyandcanleadtohealthprotectiveactions |